Regeneron Pharmaceuticals Inc (REGN) is traded on NASDAQ in USA. It is located in NEW YORK, U.S.A and employs 4,786 people. Regeneron Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with current market capitalization of 47.22 B. Regeneron Pharmaceuticals Inc conducts business under Healthcare
sector and is part of Biotechnology
industry. This company has 104.69 M outstanding shares of which 2.44 M shares are at this time shorted by private and institutional investors with about 3.33 trading days to cover.
REGENERON PHARMAC currently holds about 1.27 B in cash with 1.35 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.96.
Check Regeneron Pharmaceuticals Probability Of Bankruptcy